In this powerful ScaleUp Radio Shorts episode, Kevin Brent and Granger Forson contrast two founders tackling very different ends of the healthcare and life sciences spectrum:

• Michael Colling-Tuck, founder of Agency Medical Marketing, is on a mission to ensure life-changing innovations get adopted by clinicians and patients.
• Prasun Chakraborty, founder of Genevation, is developing personalised cancer vaccines using cutting-edge AI and immunotherapy.

One is solving the problem of visibility and market traction. The other is solving for scientific possibility and clinical impact. Yet both share a relentless sense of purpose and founder resilience.

What You'll Learn:

✅ The commercial vs scientific ends of the innovation lifecycle ✅ How founder motivation shapes business strategy ✅ Different approaches to funding, operations and visibility ✅ Why isolation, pressure and resilience are universal for founders

Standout Quotes:

"Only 5% of life-changing medical innovations succeed – not because they don't work, but because no one knows about them." – Michael "I think like a patient so I can build for the patient." – Prasun

Key Takeaway:

Innovation dies without commercial traction, and commercial traction is meaningless without innovation. Founders must either build the bridge—or be the breakthrough.